Keros Capital Update: Emerging Growth Research, LLP Issues a Speculative Buy Rating and $4 Target Price for Kraig Biocraft Labs
8/5/2008 8:29:44 AM - Canada NewsWire
LANSING, MI, Aug. 5, 2008 (Canada NewsWire via COMTEX News Network) --
Kraig Biocraft Laboratories, Inc. (OTCBB: KBLB), Emerging Growth Research, LLP issued a report late last month on Kraig Biocraft Labs putting a Speculative BUY rating and a target price of $4 a share. Analyst Joseph Noel said "We are clearly excited about this company's prospects to develop a 'super fiber' that can be sold into the technical textiles industry".
The report states the company is in possession of the coded gene sequences relating to spider silk production and is currently working on microinjections of this material into silkworm eggs. No requirement for FDA approval enables the company to fast track into production, licensing agreements or direct sale once microinjection is successful, which is estimated by the end of 2008.
The report is available for free download at: http://www.kraiglabs.com/pdf/KBLBReport.pdf
Kraig Biocraft Labs Kraig Biocraft Laboratories is a technology company focused on the development of commercially significant high-performance polymers, technical fibers and diverse platform technologies. Based on proprietary genetic engineering technology, Kraig is working to develop and produce polymers and protein-based materials including Spider Silk.
To receive immediate notification of all companies Keros Capital covers, enter your email at http://www.keroscapital.com/render/?page=joinus
Kraig Biocraft Labs trades on the OTC Bulletin Board exchange under the symbol KBLB, other Bulletin Board and Pink Sheet to watch are: Nutracea (OTCBB: NTRZ) up 51% on 5.7 million shares, Neomedia Technologies Inc (OTCBB: NEOM) up 75% on 43.7 million shares, Quest Minerals and Mining LTD (OTCBB: QMNM) up 18% on 43 million shares,
Nasdaq stocks to watch include Sirius Satellite Radio Inc (Nasdaq: SIRI) down 4.8% on 180 million shares, PeopleSupport Inc (Nasdaq: PSPT) up 25% on 6.4 million shares, Amgen Inc (Nasdaq: AMGN) up 1.4% on 10 million shares, Biogen Idec Inc. (Nasdaq: BIIB) down less than 1% on 8.9 million shares, Gilead Sciences Inc (Nasdaq: GILD) up less than 1% on 6.2 million shares, Vertex Pharmaceuticals Inc (Nasdaq: VRTX) down 8.4% on 10 million shares, Celgene Corp (Nasdaq: CELG) down 1% on 3.7 million shares, Sepacor Inc (Nasdaq: SEPR) up 1% on 2.6 million shares.
NYSE stocks to watch: Genentech Inc (NYSE: DNA) up less than 1% on 2.4 million shares.
Disclosure: All material herein was prepared by Keros Capital Inc. (Keros) based upon information believed to be reliable. The information contained herein is not guaranteed by Keros to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Keros is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.keroscapital.com or mentioned herein. Keros has been compensated two thousand five hundred dollars for KBLB. Keros affiliates, officers, directors and employees may own shares and may buy and sell additional shares of the company mentioned herein and may profit in the event those shares rise in value. Keros will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SOURCE: Keros Capital
Jim Mav, (973) 979-3705
Copyright (C) 2008 CNW Group. All rights reserved.
|
Thread abonnieren
ETF-Sparplan